Pan-European PRECISE consortium aims to predict cancer vulnerabilities before experimental testing
Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping…
Read the full articleYou might also wanna read
The Quiet Revolution in Precision Medicine
From beans for men's hearts to proteins that block cancer spread, researchers worldwide are cracking diseases open with unprecedented precis
10x Genomics, Cleveland Clinic Collaborate on Single-Cell, Spatial Diagnostics
The partners hope to better understand the mechanisms underlying therapeutic response in a number of major cancer types, including bladder c
Científicos financiados por los Institutos Nacionales de la Salud descubren pistas sobre las lesiones precancerosas y la biología tumoral
En nuevos estudios publicados por la Red del Atlas de Tumores Humanos (HTAN) del Instituto Nacional del Cáncer (NCI), se explora la función
DoH and MIT– Koch Institute partner to advance AI-driven Cancer research
The partnership will connect world-class research expertise with the infrastructure, talent and capabilities required to accelerate the tran
Building a National Cancer Research Ecosystem: Key Takeaways from Algeria’s First International Conference on Cancer Research
Cancer control is increasingly shaped not only by access to diagnosis and treatment, but also by a country’s ability to generate scientific
Harmonizing standards and resources for the medical genome
Nature, Published online: 01 July 2026; doi:10.1038/s41586-026-10621-5 This Perspective examines the challenges and opportunities of genomic
Comments
Sign in to join the conversation.
No comments yet. Be the first.